Recruiting NA HPV-related Lower Genital Tract Neoplasias

New treatment option for HPV-related Lower Genital Tract Neoplasias

Official title Screening Women With Prior HPV for Anal Neoplasia

ClinicalTrials.gov ID: NCT05217940

What this study is testing

What it's testing
The goal of this single arm trial is to prospectively evaluate screening methods for anal cancer precursors in HIV uninfected women with a history of lower genital tract neoplasias and cancers.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 35 and older, women only

You may be able to join if

  • Women with a history of pathologically proven high-grade genital HPV-associated neoplastic disease (cervical intraepithelial neoplasia 2+, vulvar...
  • Documented HIV seronegativity
  • Aged 35 years and older
  • Seen in the Mount Sinai Health System (MSHS) or the Harris Health System (HHS) in Houston
  • English or Spanish speaking

You likely can't join if

  • prior history or high resolution anoscopy

The study team makes the final eligibility decision.

Where it's taking place

  • New York, New York, United States
  • Charleston, South Carolina, United States
  • Houston, Texas, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 35 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include New York, New York, United States; Charleston, South Carolina, United States; Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.